(2-phenylethyl)phosphinic acid | 86552-40-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: (2-phenylethyl)phosphinic acid
• 英文别名: phenethylphosphinic acid；(2-phenylethyl)phosphonous acid；2-Phenylethylphosphinic acid
• CAS: 86552-40-1
• 化学式: C₈H₁₁O₂P
• 分子量: 170.148
• InChiKey: GPRQVQIDIJJIHD-UHFFFAOYSA-N

物化性质

• 沸点：
  327.8±35.0 °C(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.8
• 重原子数：
  11
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  37.3
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  (2-phenylethyl)phosphinic acid 在 sodium hydride 、 N,N'-二环己基碳二亚胺 作用下， 以 四氢呋喃 、 二氯甲烷 为溶剂， 反应 18.0h， 生成 Dibenzyl 2-[[2-phenylethyl(phenylmethoxy)phosphoryl]methyl]pentanedioate
  参考文献：
  名称：

  Design and Pharmacological Activity of Phosphinic Acid Based NAALADase Inhibitors

  摘要：

  A novel series of phosphinic acid based inhibitors of the neuropeptidase NAALADase are described in this work. This series of compounds is the most potent series of inhibitors of the enzyme described to date. In addition, we have shown that these compounds are protective in animal models of neurodegeneration. Compound 34 significantly prevented neurodegeneration in a middle cerebral artery occlusion model of cerebral ischemia. In addition, in the chronic constrictive mc del of neuropathic pain, compound 34 significantly attenuated the hypersensitivity observed with saline-treated animals. These data suggest that NAALADase inhibition may provide a new approach for the treatment of both neurodegenerative disorders and peripheral neuropathies.

  DOI：

  10.1021/jm0001774
• 作为产物：
  描述：

  ethyl 2-phenylethyl-H-phosphinate 在 sodium hydroxide 作用下， 生成 (2-phenylethyl)phosphinic acid
  参考文献：
  名称：

  Phosphonamidate compounds

  摘要：

  式中X为氨基酸或酯。这些化合物具有抑制血管紧张素转化酶和脑啡肽酶的活性。因此它们可用作降压和镇痛剂。

  公开号：

  US04432972A1

文献信息

• [EN] AMINOPEPTIDASE A INHIBITORS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME<br/>[FR] INHIBITEURS D'AMINOPEPTIDASE A ET COMPOSITIONS PHARMACEUTIQUES LES COMPRENANT
  申请人：QUANTUM GENOMICS

  公开号：WO2020084131A1

  公开（公告）日：2020-04-30

  The present invention relates to a novel compound, to a composition comprising the same, to methods for preparing the compound, and the use of this compound in therapy. In particular, the present invention relates to compound that is useful in the treatment and prevention of primary and secondary arterial hypertension, ictus, myocardial ischaemia, cardiac and renal insufficiency, myocardial infarction, peripheral vascular disease, diabetic proteinuria, Syndrome X and glaucoma.

  本发明涉及一种新型化合物，包括该化合物的组合物，制备该化合物的方法，以及该化合物在治疗中的应用。具体而言，本发明涉及一种在治疗和预防原发性和继发性动脉高血压、中风、心肌缺血、心脏和肾功能不全、心肌梗死、外周血管疾病、糖尿病蛋白尿、X综合征和青光眼中有用的化合物。
• Structure Property Relationships of Carboxylic Acid Isosteres
  作者：Pierrik Lassalas、Bryant Gay、Caroline Lasfargeas、Michael J. James、Van Tran、Krishna G. Vijayendran、Kurt R. Brunden、Marisa C. Kozlowski、Craig J. Thomas、Amos B. Smith、Donna M. Huryn、Carlo Ballatore

  DOI：10.1021/acs.jmedchem.5b01963

  日期：2016.4.14

  physicochemical properties of carboxylic acid isosteres would be desirable to enable more informed decisions of potential replacements to be used for analog design. Herein we report the structure–property relationships (SPR) of 35 phenylpropionic acid derivatives, in which the carboxylic acid moiety is replaced with a series of known isosteres. The data set generated provides an assessment of the relative

  用替代结构或（生物）-等位异构体取代羧酸是药物化学中的经典策略。基本的基本原理是，通过维持对于生物活性至关重要的羧酸特征，但适当地改变其理化性质，可以得到改进的类似物。在这种情况下，需要对羧酸等排物的物理化学性质进行系统的评估，以使对于类似设计的潜在替代品的更明智的决定成为可能。本文中，我们报告了35种苯基丙酸衍生物的结构-性质关系（SPR），其中羧酸部分被一系列已知的等排物取代。生成的数据集提供了对这些替代物与羧酸类似物相比对物理化学性质的相对影响的评估。因此，本研究为如何合理应用羧酸官能团的等排取代物提供了一个框架。
• Amidoalkylation of hydrophosphoryl compounds
  作者：M. E. Dmitriev、E. A. Rossinets、V. V. Ragulin

  DOI：10.1134/s1070363211060041

  日期：2011.6

  interaction of hydrophosphoryl compounds previously synthesized with biscarbamates in acetic anhydride and other solvents, the influence of the structure of phosphorus component and biscarbamate, and the effect of acid catalysis on the course of this two-component reaction. A new version of the mechanism of the three-component reaction of amidoalkylation of hydrophosphoryl compounds is suggested: it is regarded

  作为构建假α，α′-二肽分子的α-氨基磷酰基片段的简便方法，开发了一种新的温和的氢化磷酰基化合物在乙酸酐和乙酰氯混合物中的酰胺基烷基化的方法。反应中间体N，N′-亚苄基-和N，N检测，分离和鉴定了'-亚烷基双氨基甲酸酯。该报告提供了以下结果：研究了先前与双氨基甲酸酯合成的氢磷酰基化合物在乙酸酐和其他溶剂中的直接相互作用，磷组分和双甲酸氨基甲酸酯的结构的影响以及酸催化对该双组分反应过程的影响。 。提出了氢磷酰基化合物酰胺烷基烷基化三组分反应机理的新形式：它被认为是一个多阶段过程，涉及到双甲氨基甲酸酯的形成阶段，然后是Arbuzov型反应阶段，中间形成酰基亚胺基阳离子和具有三价磷的P-OAc衍生物。
• Recent advances in phosphorus–carbon bond formation: synthesis of H-phosphinic acid derivatives from hypophosphorous compounds
  作者：Jean-Luc Montchamp

  DOI：10.1016/j.jorganchem.2004.10.005

  日期：2005.5

  This account summarizes the research conducted in our laboratory over the past five years. New methodologies were devised for the formation of P–C bonds with a focus on the reactions of hypophosphorous acid derivatives. Three types of reactions have been developed: palladium-catalyzed cross-coupling, room-temperature radical addition, and palladium-catalyzed addition. Our results are summarized in

  该报告总结了过去五年来我们实验室进行的研究。设计了新的方法来形成P-C键，重点是次磷酸衍生物的反应。已经开发出三种类型的反应：钯催化的交叉偶联，室温自由基加成和钯催化的加成。我们在所有这些领域中总结了我们的结果，其中包括一些我们的最新数据。（1）我们的钯催化交叉偶联已扩展到烷基次膦酸酯与各种芳基，杂芳基甚至烯基亲电试剂的直接偶联。（2）在自由基条件下添加次磷酸钠从烯烃延伸至炔烃。
• Method for the production of alkylphosphonic acids, esters, and salts by oxidizing alkylphosphonous acids, and use thereof
  申请人：Hill Michael

  公开号：US09018413B2

  公开（公告）日：2015-04-28

  The invention relates to a method for producing monocarboxy-functionalized dialkylphosphinic acids, esters, and salts, characterized in that a) a phosphinic acid source (I) is reacted with olefins (IV) in the presence of a catalyst A to obtain an alkylphosphonous acid, the salt or ester (II) thereof, and b) the obtained alkylphosphonous acid, the salt or ester (II) thereof is reacted with an oxidizing agent or with an oxidizing agent and water or with oxygen and water in the presence of a catalyst B to obtain the alkylphosphonic acid derivative (III), wherein R1, R2, R3, R4 are identical or different from each other and independently represent, inter alia, H, C1-C18-alkyl, C6-C18-aryl, C6-C18-aralkyl, C6-C18-alkylaryl, X and Y are identical or different from each other and independently represent H, C1-C18-alkyl, C6-C18-aryl, C6-C18-aralkyl, C6-C18-alkylaryl, Mg, Ca, Al, Sb, Sn, Ge, Ti, Fe, Zr, Zn, Ce, Bi, Sr, Mn, Cu, Ni, Li, Na, K and/or a protonated nitrogenous base, and catalysts A and B are transition metals and/or transition metal compounds and/or catalyst systems composed of a transition metal and/or a transition metal compound and at least one ligand.

  该发明涉及一种生产单羧基功能化二烷基膦酸、酯和盐的方法，其特征在于a)在催化剂A的存在下，将膦酸源(I)与烯烃(IV)反应，得到一种烷基膦酸、其盐或酯(II)，b)将所得的烷基膦酸、其盐或酯(II)与氧化剂或与氧化剂和水或与氧气和水在催化剂B的存在下反应，得到烷基膦酸衍生物(III)，其中R1、R2、R3、R4相同或不同，独立表示H、C1-C18-烷基、C6-C18-芳基、C6-C18-芳基烷基、C6-C18-烷基芳基，X和Y相同或不同，独立表示H、C1-C18-烷基、C6-C18-芳基、C6-C18-芳基烷基、C6-C18-烷基芳基、Mg、Ca、Al、Sb、Sn、Ge、Ti、Fe、Zr、Zn、Ce、Bi、Sr、Mn、Cu、Ni、Li、Na、K和/或质子化的氮碱基，催化剂A和B是过渡金属和/或过渡金属化合物和/或由过渡金属和/或过渡金属化合物与至少一种配体组成的催化体系。